Actelion spinout Idorsia hits goals in insomnia phase 2, sparking stock rise and talk of partnering up for pivotal trial | Fierce Biotech
Clozel's CHF1bn Actelion Spin-Out Idorsia Awaits Janssen Buy-In :: Scrip
Jean-Paul Clozel
Molecular Millionaire: Jean-Paul Clozel of Actelion
Startup Guide on Twitter: "Jean-Paul and Martine Clozel are experienced founders and leading figures in the Basel Area. After Actelion, the first company they cofounded, was acquired by Johnson & Johnson, they
Actelion never made offer for ZS Pharma: CEO
Actelion offers sweetener to stave off attacks - SWI swissinfo.ch
Biotech: Jean-Paul Clozel kämpft bei Idorsia mit Gegenwind
Actelion: Die Knackpunkte eines Deals mit Johnson & Johnson | Tages-Anzeiger
Actelion Could Boost Takeover Price for Johnson & Johnson
Jean-Paul Clozel
Big Boss - Jean-Paul Clozel, CEO Idorsia - Play RTS
J&J seals $30bn Swiss Actelion deal | The Peninsula Qatar
Was plant das Ehepaar Clozel? | NZZ
J&J/Actelion: high pressure sale | Financial Times
PharmaBoardroom - Jean-Paul Clozel - CEO, Idorsia (October 2017)
J&J Woos Billionaire Doctors Who Don't Need Cash in Actelion Bid - Bloomberg
Actelion Began in a Garage—Now Its Founding Couple Has $1 Billion and a New Biotech Firm - WSJ
Martine et Jean-Paul Clozel, le couple vedette de la pharmacie mondiale
Who wants to be a billionaire? Not Actelion's founder and CEO, if it means selling out | Fierce Pharma
Actelion's Fate May Rest on Structure, Not Price, as Clozel Holds Firm - TheStreet
Actelion's Jean-Paul Clozel aims to keep group's independence | Financial Times
How is Actelion Spin-Off Idorsia Doing One Year Later?
